The Social Model of Disability: Dichotomy between Impairment and Disability
ANASTASIOU, Dimitris, KAUFFMAN, James M
Published in The Journal of medicine and philosophy (01.08.2013)
Published in The Journal of medicine and philosophy (01.08.2013)
Get full text
Journal Article
KPT-8602, a second-generation inhibitor of XPO1-mediated nuclear export, is well tolerated and highly active against AML blasts and leukemia-initiating cells
Etchin, J, Berezovskaya, A, Conway, A S, Galinsky, I A, Stone, R M, Baloglu, E, Senapedis, W, Landesman, Y, Kauffman, M, Shacham, S, Wang, J C Y, Look, A T
Published in Leukemia (01.01.2017)
Published in Leukemia (01.01.2017)
Get full text
Journal Article
CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications
Tai, Y-T, Landesman, Y, Acharya, C, Calle, Y, Zhong, M Y, Cea, M, Tannenbaum, D, Cagnetta, A, Reagan, M, Munshi, A A, Senapedis, W, Saint-Martin, J R, Kashyap, T, Shacham, S, Kauffman, M, Gu, Y, Wu, L, Ghobrial, I, Zhan, F, Kung, A L, Schey, S A, Richardson, P, Munshi, N C, Anderson, K C
Published in Leukemia (01.01.2014)
Published in Leukemia (01.01.2014)
Get full text
Journal Article
Next-generation XPO1 inhibitor shows improved efficacy and in vivo tolerability in hematological malignancies
Hing, Z A, Fung, H Y J, Ranganathan, P, Mitchell, S, El-Gamal, D, Woyach, J A, Williams, K, Goettl, V M, Smith, J, Yu, X, Meng, X, Sun, Q, Cagatay, T, Lehman, A M, Lucas, D M, Baloglu, E, Shacham, S, Kauffman, M G, Byrd, J C, Chook, Y M, Garzon, R, Lapalombella, R
Published in Leukemia (01.12.2016)
Published in Leukemia (01.12.2016)
Get full text
Journal Article
KPT-330 has antitumour activity against non-small cell lung cancer
SUN, H, HATTORI, N, NAKAMAKI, T, KOEFFLER, H. P, CHIEN, W, SUN, Q, SUDO, M, E-LING, G. L, DING, L, LIM, S. L, SHACHAM, S, KAUFFMAN, M
Published in British journal of cancer (15.07.2014)
Published in British journal of cancer (15.07.2014)
Get full text
Journal Article
Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells
Etchin, J, Sun, Q, Kentsis, A, Farmer, A, Zhang, Z C, Sanda, T, Mansour, M R, Barcelo, C, McCauley, D, Kauffman, M, Shacham, S, Christie, A L, Kung, A L, Rodig, S J, Chook, Y M, Look, A T
Published in Leukemia (01.01.2013)
Published in Leukemia (01.01.2013)
Get full text
Journal Article
Phase 2 study of the Exportin 1 inhibitor selinexor in patients with recurrent gynecological malignancies
Vergote, I.B., Lund, B., Peen, U., Umajuridze, Z., Mau-Sorensen, M., Kranich, A., Van Nieuwenhuysen, E., Haslund, C., Nottrup, T., Han, S.N., Concin, N., Unger, T.J., Chai, Y., Au, N., Rashal, T., Joshi, A., Crochiere, M., Landesman, Y., Shah, J., Shacham, S., Kauffman, M., Mirza, M.R.
Published in Gynecologic oncology (01.02.2020)
Published in Gynecologic oncology (01.02.2020)
Get full text
Journal Article
Big data from small animals: integrating multi-level environmental data into the Dog Aging Project
Xue, D, Collins, D, Kauffman, M, Dunbar, M, Crowder, K, Schwartz, S M, Ruple, A
Published in Revue scientifique et technique (International Office of Epizootics) (01.05.2023)
Published in Revue scientifique et technique (International Office of Epizootics) (01.05.2023)
Get more information
Journal Article
Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276
Schmidt, J, Braggio, E, Kortuem, K M, Egan, J B, Zhu, Y X, Xin, C S, Tiedemann, R E, Palmer, S E, Garbitt, V M, McCauley, D, Kauffman, M, Shacham, S, Chesi, M, Bergsagel, P L, Stewart, A K
Published in Leukemia (01.12.2013)
Published in Leukemia (01.12.2013)
Get full text
Journal Article
How have advances in genetic technology modified movement disorder nosology?
Sturchio, A., Marsili, L., Mahajan, A., Grimberg, M. B., Kauffman, M. A., Espay, A. J.
Published in European journal of neurology (01.08.2020)
Published in European journal of neurology (01.08.2020)
Get full text
Journal Article
A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma
Jagannath, S., Barlogie, B., Berenson, J., Siegel, D., Irwin, D., Richardson, P. G., Niesvizky, R., Alexanian, R., Limentani, S. A., Alsina, M., Adams, J., Kauffman, M., Esseltine, D.‐L., Schenkein, D. P., Anderson, K. C.
Published in British journal of haematology (01.10.2004)
Published in British journal of haematology (01.10.2004)
Get full text
Journal Article